| Product Code: ETC6649379 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Age-Related Macular Degeneration Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Age-Related Macular Degeneration Market - Industry Life Cycle |
3.4 Canada Age-Related Macular Degeneration Market - Porter's Five Forces |
3.5 Canada Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Canada Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Age-Related Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) due to aging population in Canada. |
4.2.2 Technological advancements in AMD diagnosis and treatment leading to better patient outcomes. |
4.2.3 Rising awareness about eye health and early detection of AMD. |
4.3 Market Restraints |
4.3.1 High cost associated with AMD treatments and therapies. |
4.3.2 Limited access to specialized healthcare services in remote areas of Canada. |
4.3.3 Regulatory challenges and stringent approval processes for new AMD drugs and therapies. |
5 Canada Age-Related Macular Degeneration Market Trends |
6 Canada Age-Related Macular Degeneration Market, By Types |
6.1 Canada Age-Related Macular Degeneration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F |
6.1.4 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F |
6.1.5 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F |
6.1.6 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Age-Related Macular Degeneration Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F |
6.2.3 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F |
6.3 Canada Age-Related Macular Degeneration Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.3.4 Canada Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Canada Age-Related Macular Degeneration Market Import-Export Trade Statistics |
7.1 Canada Age-Related Macular Degeneration Market Export to Major Countries |
7.2 Canada Age-Related Macular Degeneration Market Imports from Major Countries |
8 Canada Age-Related Macular Degeneration Market Key Performance Indicators |
8.1 Average waiting time for AMD diagnosis and treatment. |
8.2 Patient satisfaction rate with AMD healthcare services. |
8.3 Percentage of AMD patients receiving timely and effective treatment. |
8.4 Rate of adoption of advanced AMD diagnostic technologies. |
8.5 Number of AMD clinical trials and research studies conducted in Canada. |
9 Canada Age-Related Macular Degeneration Market - Opportunity Assessment |
9.1 Canada Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Canada Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Age-Related Macular Degeneration Market - Competitive Landscape |
10.1 Canada Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 Canada Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here